Coronary vasoconstriction: where do we stand in 1999. An important, multifaceted but elusive role.
Maseri
A
A
Crea
F
F
Lanza
G A
GA
D000787:Angina Pectoris / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D000788:Angina Pectoris, Variant / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D003326:Coronary Circulation; D003327:Coronary Disease / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D003329:Coronary Vasospasm / Q000209:etiology / Q000503:physiopathology; D003331:Coronary Vessels / Q000502:physiology*; D004562:Electrocardiography; D006801:Humans; D008833:Microcirculation; D017566:Microvascular Angina / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D009203:Myocardial Infarction / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D014661:Vasoconstriction; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents